<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Decentralized Clinical Trials for Drugs, Biological Products, and Devices; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Decentralized Clinical Trials for Drugs, Biological Products, and Devices; Draft Guidance for Industry, Investigators, and Other Stakeholders; Availability</h1>
    <p class="timestamp">Published: 2023-05-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry, investigators, and other stakeholders entitled "Decentralized Clinical Trials for Drugs, Biological Products, and Devices." This draft guidance provides recommendations for sponsors, investigators, and other stakeholders regarding the implementation of decentralized clinical trials (DCTs) for drugs, biological products, and devices. In this draft guidance, a DCT refers to a clinical ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-09399</p>
    <p><strong>Publication Date:</strong> 2023-05-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/05/03/2023-09399/decentralized-clinical-trials-for-drugs-biological-products-and-devices-draft-guidance-for-industry">https://www.federalregister.gov/documents/2023/05/03/2023-09399/decentralized-clinical-trials-for-drugs-biological-products-and-devices-draft-guidance-for-industry</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-09399</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
